A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease

Clinical trial NCT00744276 · COMPLETED

Trial details

NCT number: NCT00744276
Sponsor: FemmePharma Global Healthcare, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fibrocystic Disease of Breast

Start date: 2007-01-01
Primary completion: 2009-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.